Y. Abe, K. Tamura, I. Sakata, J. Ishida, Y. Ozeki et al., Clinical implications of 18F-fluorodeoxyglucose positron emission tomography/computed tomography at delayed phase for diagnosis and prognosis of malignant pleural mesothelioma, Oncology Reports, vol.27, pp.333-341, 2012.
DOI : 10.3892/or.2011.1520

R. Abgral, L. Roux, P. Keromnes, N. Rousset, J. Valette et al., Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma, European Journal of Nuclear Medicine and Molecular Imaging, vol.51, issue.12, pp.1839-1886, 2012.
DOI : 10.1007/s00259-012-2213-x

URL : https://hal.archives-ouvertes.fr/hal-00730875

R. Abgral, L. Roux, P. Rousset, J. Querellou, S. Valette et al., Prognostic value of dual-time-point 18F-FDG PET-CT imaging in patients with head and neck squamous cell carcinoma, Nuclear Medicine Communications, vol.34, issue.6, pp.551-557, 2013.
DOI : 10.1097/MNM.0b013e32836089ab

URL : https://hal.archives-ouvertes.fr/hal-00831504

1. Does and . Pet, CT improve the detection of posttreatment recurrence of head and neck squamous cell carcinoma in patients negative for disease on clinical follow-up?, J Nucl Med, vol.50, pp.24-33, 2009.

H. Aerts, L. Dubois, L. Perk, P. Vermaelen, G. Van-dongen et al., Disparity Between In Vivo EGFR Expression and 89Zr-Labeled Cetuximab Uptake Assessed with PET, Journal of Nuclear Medicine, vol.50, issue.1
DOI : 10.2967/jnumed.108.054312

P. Ahn and M. Garg, Positron Emission Tomography/Computed Tomography for Target Delineation in Head and Neck Cancers, Seminars in Nuclear Medicine, vol.38, issue.2, pp.141-149, 2008.
DOI : 10.1053/j.semnuclmed.2007.11.002

J. Akervall, R. Michalides, H. Mineta, A. Balm, A. Borg et al., Amplification of cyclin D1 in squamous cell carcinoma of the head and neck and the prognostic value of chromosomal abnormalities and cyclin D1 overexpression, Cancer, vol.79, issue.2, pp.380-389, 1997.
DOI : 10.1002/(SICI)1097-0142(19970115)79:2<380::AID-CNCR22>3.3.CO;2-5

A. Al-ibraheem, A. Buck, B. Krause, K. Scheidhauer, and M. Schwaiger, Clinical Applications of FDG PET and PET/CT in Head and Neck Cancer, Journal of Oncology, vol.47, issue.2, pp.208725-208736, 2009.
DOI : 10.1158/1078-0432.CCR-07-0528

J. Al-swiahb, C. Huang, F. Fang, H. Chuang, H. Huang et al., Prognostic Impact of p16, p53, Epidermal Growth Factor Receptor, and Human Papillomavirus in Oropharyngeal Cancer in a Betel Nut???Chewing Area, Archives of Otolaryngology???Head & Neck Surgery, vol.136, issue.5, pp.502-510, 2010.
DOI : 10.1001/archoto.2010.47

K. Ang, A. Trotti, B. Brown, A. Garden, R. Foote et al., Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.3, pp.571-579, 2001.
DOI : 10.1016/S0360-3016(01)01690-X

K. Ang, J. Harris, R. Wheeler, R. Weber, D. Rosenthal et al., Human Papillomavirus and Survival of Patients with Oropharyngeal Cancer, New England Journal of Medicine, vol.363, issue.1, pp.24-35, 2010.
DOI : 10.1056/NEJMoa0912217

K. Ang, A. Trotti, B. Brown, A. Garden, R. Foote et al., Randomized trial addressing risk features and time factors of surgery plus radiotherapy in advanced head-and-neck cancer, International Journal of Radiation Oncology*Biology*Physics, vol.51, issue.3, pp.571-579, 2001.
DOI : 10.1016/S0360-3016(01)01690-X

J. Asper, W. Morrison, D. Rosenthal, A. Ahamad, K. Ang et al., Impact of changes to the American Joint Committee on Cancer T classification on outcome prediction in patients with oropharyngeal cancer, Cancer, vol.26, issue.9, pp.1950-1957, 2006.
DOI : 10.1002/cncr.21867

T. Aukema, I. Kappers, R. Olmos, H. Codrington, H. Van-tinteren et al., Is 18F-FDG PET/CT Useful for the Early Prediction of Histopathologic Response to Neoadjuvant Erlotinib in Patients with Non-Small Cell Lung Cancer?, Journal of Nuclear Medicine, vol.51, issue.9, pp.1344-1352, 2010.
DOI : 10.2967/jnumed.110.076224

N. Avril, S. Sassen, B. Schmalfeldt, J. Naehrig, S. Rutke et al., Prediction of Response to Neoadjuvant Chemotherapy by Sequential F-18-Fluorodeoxyglucose Positron Emission Tomography in Patients With Advanced-Stage Ovarian Cancer, Journal of Clinical Oncology, vol.23, issue.30, pp.7445-53, 2005.
DOI : 10.1200/JCO.2005.06.965

J. Bailet, E. Abemayor, B. Jabour, R. Hawkins, C. Ho et al., Positron Emission Tomography, The Laryngoscope, vol.102, issue.3, pp.281-289, 1992.
DOI : 10.1288/00005537-199203000-00010

B. Barry, D. Raucourt, and D. , Post-therapeutic follow-up of head and neck cancer, Rev Prat, vol.56, pp.1684-90, 2006.

A. Belot, P. Grosclaude, and N. Bossard, Cancer incidence and mortality in France over the period 1980-200518F]FDG-PET predicts complete pathological response of breast cancer to neoadjuvant chemotherapy, Cancer. Rev Epidemiol Sante Publique Eur J Nucl Med Mol Imaging, vol.1125634, issue.23, pp.995-1000159, 2007.

E. Berthelet, G. Shenouda, M. Black, M. Picariello, and L. Rochon, Sarcomatoid carcinoma of the head and neck, The American Journal of Surgery, vol.168, issue.5, pp.455-463, 1994.
DOI : 10.1016/S0002-9610(05)80098-4

E. Bombarderi and F. Crippa, The increasing impact of PET in the diagnostic work-up of cancer patients, pp.75-121, 2002.

X. Bontemps, R. Abgral, C. Leleu, A. Turzo, G. Valette et al., Comparaison de diff??rentes m??thodes de segmentation en TEP/TDM pour le ciblage en radioth??rapie des carcinomes ??pidermo??des des VADS, M??decine Nucl??aire, vol.36, issue.6, pp.303-315, 2012.
DOI : 10.1016/j.mednuc.2012.03.003

J. Braams, J. Pruim, A. Kole, P. Nikkels, W. Vaalburg et al., Detection of unknown primary head and neck tumors by positron emission tomography, International Journal of Oral and Maxillofacial Surgery, vol.26, issue.2, pp.112-117, 1997.
DOI : 10.1016/S0901-5027(05)80829-X

S. Breen, J. Publicover, D. Silav, and S. , Intraobserver and Interobserver Variability in GTV Delineation on FDG-PET-CT Images of Head and Neck Cancers, International Journal of Radiation Oncology*Biology*Physics, vol.68, issue.3, pp.763-70, 2007.
DOI : 10.1016/j.ijrobp.2006.12.039

J. Bussink, C. Van-herpen, J. Kaanders, and W. Oyen, PET-CT for response assessment and treatment adaptation in head and neck cancer, The Lancet Oncology, vol.11, issue.7, pp.661-670, 2010.
DOI : 10.1016/S1470-2045(09)70353-5

P. Byström, A. Berglund, U. Garske, H. Jacobsson, A. Sundin et al., Early prediction of response to first-line chemotherapy by sequential [18F]-2-fluoro-2-deoxy-D-glucose positron emission tomography in patients with advanced colorectal cancer, Annals of Oncology, vol.20, issue.6, pp.1057-61, 2009.
DOI : 10.1093/annonc/mdn744

R. Cabanillas, J. Rodrigo, A. Astudillo, F. Domínguez, C. Suárez et al., P53 expression in squamous cell carcinomas of the supraglottic larynx and its lymph node metastases, Cancer, vol.46, issue.9, pp.1791-1799, 2007.
DOI : 10.1002/cncr.22646

C. Caldwell, K. Mah, Y. Ung, C. Danjoux, J. Balogh et al., Observer variation in contouring gross tumor volume on CT: the impact of 18FDG-hybrid PET fusion, Int J Radiat Oncol Biol Phys, vol.15, pp.923-954, 2001.

K. Chao, W. Bosch, S. Mutic, J. Lewis, F. Dehdashti et al., A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.49, issue.4, pp.1171-82, 2001.
DOI : 10.1016/S0360-3016(00)01433-4

F. Chiesa, S. Mauri, N. Tradati, L. Calabreses, G. Giugliano et al., Surfing prognostic factors in head and neck cancer at the Millennium, Oral Oncology, vol.35, issue.6, pp.590-596, 1999.
DOI : 10.1016/S1368-8375(99)00043-3

K. Choi, L. Yoo, E. Han, Y. Kim, G. Kim et al., Prognostic Value of Metabolic Tumor Volume Measured by 18F-FDG PET/CT in Locally Advanced Head and Neck Squamous Cell Carcinomas Treated by Surgery, Nuclear Medicine and Molecular Imaging, vol.43, issue.1, pp.43-51, 2011.
DOI : 10.1007/s13139-010-0063-7

K. Chu, J. Murphy, T. La, T. Krakow, A. Iagaru et al., Prognostic value of metabolic tumor volume and velocity in predicting head-and-neck cancer outcomes, Int J

H. Chung, H. Kwon, K. Kang, N. Park, Y. Song et al., Prognostic Value of Preoperative Metabolic Tumor Volume and Total Lesion Glycolysis in Patients with Epithelial Ovarian Cancer, Annals of Surgical Oncology, vol.34, issue.Suppl 1, pp.1966-72, 2012.
DOI : 10.1245/s10434-011-2153-x

M. Chung, H. Jeong, S. Park, J. Jang, Y. Son et al., Metabolic tumor volume of [18F]-fluorodeoxyglucose positron emission tomography/computed tomography predicts short-term outcome to radiotherapy with or without chemotherapy in pharyngeal cancer Radiation treatment planning with an integrated positron emission and computer tomography (PET/CT): a feasibility study, Clin Cancer Res. Int J Radiat Oncol Biol Phys, vol.15, issue.57, pp.5861-8853, 2003.

D. Cobben, B. Van-der-laan, B. Maas, W. Vaalburg, A. Suurmeijer et al., 18F-FLT PET for visualization of laryngeal cancer: comparison with 18F-FDG PET, J Nucl Med, vol.45, pp.226-257, 2004.

O. Cojocariu, F. Huguet, M. Lefevre, and S. Périé, Prognosis and predictive factors in headand-neck cancers, Bull Cancer, vol.96, pp.369-78, 2009.

C. Conessa, S. Hervé, H. Foehrenbach, and J. Poncet, Fdg-Pet Scan in Local Follow-up of Irradiated Head and Neck Squamous Cell Carcinomas, Annals of Otology, Rhinology & Laryngology, vol.26, issue.8, pp.628-663, 2004.
DOI : 10.1177/000348940411300806

J. Daisne, T. Duprez, B. Weynand, M. Lonneux, M. Hamoir et al., Tumor Volume in Pharyngolaryngeal Squamous Cell Carcinoma: Comparison at CT, MR Imaging, and FDG PET and Validation with Surgical Specimen, Radiology, vol.233, issue.1, pp.93-100, 2004.
DOI : 10.1148/radiol.2331030660

J. Daisne, M. Sibomana, A. Bol, G. Cosnard, M. Lonneux et al., Evaluation of a multimodality image (CT, MRI and PET) coregistration procedure on phantom and head and neck cancer patients: accuracy, reproducibility and consistency, Radiotherapy and Oncology, vol.69, issue.3, pp.237-282, 2003.
DOI : 10.1016/j.radonc.2003.10.009

J. Daisne, M. Sibomana, A. Bol, T. Doumont, M. Lonneux et al., Tri-dimensional automatic segmentation of PET volumes based on measured source-to-background ratios: influence of reconstruction algorithms, Radiotherapy and Oncology, vol.69, issue.3, pp.247-50, 2003.
DOI : 10.1016/S0167-8140(03)00270-6

B. Denhart, A. Guidi, K. Tognazzi, H. Dvorak, and L. Brown, Vascular permeability factor/vascular endothelial growth factor and its receptors in oral and laryngeal squamous-cell carcinoma and dysplasia, Lab Invest, vol.77, pp.659-64, 1997.

D. Martino, E. Nowak, B. Hassan, H. Hausmann, R. Adam et al., Diagnosis and Staging of Head and Neck Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.126, issue.12, pp.1457-61, 2000.
DOI : 10.1001/archotol.126.12.1457

E. Dibble, A. Alvarez, M. Truong, G. Mercier, E. Cook et al., 18F-FDG Metabolic Tumor Volume and Total Glycolytic Activity of Oral Cavity and Oropharyngeal Squamous Cell Cancer: Adding Value to Clinical Staging, Journal of Nuclear Medicine, vol.53, issue.5, pp.709-724, 2012.
DOI : 10.2967/jnumed.111.099531

L. Strauss, Prediction of Progression-Free Survival in Patients With Multiple Myeloma Following Anthracycline-Based Chemotherapy Based on Dynamic FDG-PET, Clinical Nuclear Medicine, vol.34, issue.9, pp.576-84, 2009.
DOI : 10.1097/RLU.0b013e3181b06bc5

T. Schmitt, Impact of dynamic 18F-FDG PET on the early prediction of therapy outcome in patients with high-risk soft-tissue sarcomas after neoadjuvant chemotherapy: a feasibility study, J Nucl Med, vol.51, issue.56, pp.551-559, 2010.

U. Haberkorn, Prediction of chemotherapy outcome in patients with metastatic soft tissue sarcomas based on dynamic FDG PET (dPET) and a multiparameter analysis, Eur J Nucl Med Mol Imaging, vol.37, pp.1481-1490, 2010.

A. Dimitrakopoulou-strauss, L. Strauss, M. Schwarzbach, C. Burger, T. Heichel et al., Dynamic PET 18F-FDG studies in patients with primary and recurrent soft-tissue sarcomas: impact on diagnosis and correlation with grading, J Nucl Med, vol.42, pp.713-733, 2001.

L. Dunnwald, R. Doot, J. Specht, J. Gralow, G. Ellis et al., PET Tumor Metabolism in Locally Advanced Breast Cancer Patients Undergoing Neoadjuvant Chemotherapy: Value of Static versus Kinetic Measures of Fluorodeoxyglucose Uptake, Clinical Cancer Research, vol.17, issue.8, pp.2400-2409, 2011.
DOI : 10.1158/1078-0432.CCR-10-2649

M. El-bassiouni, I. Ciernik, and J. Davis, [18FDG] PET-CT-Based Intensity-Modulated Radiotherapy Treatment Planning of Head and Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.69, issue.1, pp.286-93, 2007.
DOI : 10.1016/j.ijrobp.2007.04.053

N. Fischbein, O. Aassar, G. Caputo, M. Kaplan, M. Singer et al., Clinical utility of positron emission tomography with 18F-fluorodeoxyglucose in detecting residual/recurrent squamous cell carcinoma of the head and neck, Am J Neuroradiol, vol.19, pp.1189-96, 1998.

J. Folkman, E. Merler, C. Abernathy, and G. Williams, ISOLATION OF A TUMOR FACTOR RESPONSIBLE FOR ANGIOGENESIS, Journal of Experimental Medicine, vol.133, issue.2, pp.275-88, 1971.
DOI : 10.1084/jem.133.2.275

P. Fouret, G. Monceaux, S. Temam, L. Lacourreye, S. Guily et al., Human Papillomavirus in Head and Neck Squamous Cell Carcinomas in Nonsmokers, Archives of Otolaryngology - Head and Neck Surgery, vol.123, issue.5, pp.513-519, 1997.
DOI : 10.1001/archotol.1997.01900050063008

X. Geets, J. Lee, A. Bol, M. Lonneux, and V. Grégoire, A gradient-based method for segmenting FDG-PET images: methodology and validation, European Journal of Nuclear Medicine and Molecular Imaging, vol.10, issue.Suppl 2, pp.1427-1465, 2007.
DOI : 10.1007/s00259-006-0363-4

W. Golusinski, P. Golusiski, J. Staczak, and J. K?osin, Ki67, p53 and cyclin D1 in the squamous cell carcinoma of head and neck, Otolaryngol Pol, vol.58, pp.777-84, 2004.

W. Golusinski, J. Olofsson, Z. Szmeja, K. Szyfter, W. Szyfter et al., Alteration of p53 gene structure and function in laryngeal squamous cell cancer, European Archives of Oto-Rhino-Laryngology, vol.15, issue.S1, pp.133-140, 1997.
DOI : 10.1007/BF02439744

M. Gonzalez-moles, I. Ruiz-avila, J. Gil-montoya, F. Esteban, and M. Bravo, Analysis of Ki-67 expression in oral squamous cell carcinoma: Why Ki-67 is not a prognostic indicator, Oral Oncology, vol.46, issue.7, pp.525-555, 2010.
DOI : 10.1016/j.oraloncology.2010.03.020

W. Goodwin, Salvage Surgery for Patients With Recurrent Squamous Cell Carcinoma of the Upper Aerodigestive Tract: When Do the Ends Justify the Means?, The Laryngoscope, vol.101, issue.2, pp.1-18, 2000.
DOI : 10.1097/00005537-200003001-00001

J. Greenberg, R. Fowler, J. Gomez, V. Mo, D. Roberts et al., Extent of extracapsular spread, Cancer, vol.36, issue.6, pp.1464-70, 2003.
DOI : 10.1002/cncr.11202

K. Greven, J. Keyes, D. Williams, W. Mcguirt, and W. Joyce, Occult primary tumors of the head and neck, Cancer, vol.34, issue.1
DOI : 10.1002/(SICI)1097-0142(19990701)86:1<114::AID-CNCR16>3.0.CO;2-E

K. Greven, D. Williams, J. Keyes, . Jr, W. Mcguirt et al., Positron emission tomography of patients with head and neck carcinoma before and after high dose irradiation, Cancer, vol.34, issue.4, pp.1355-1364, 1994.
DOI : 10.1002/1097-0142(19940815)74:4<1355::AID-CNCR2820740428>3.0.CO;2-I

A. Gupta, J. Lee, W. Wilke, H. Quon, G. Smith et al., Radiation response in two HPV-infected head-and-neck cancer cell lines in comparison to a non-HPV-infected cell line and relationship to signaling through AKT Dynamic positron emission tomography with F-18 fluorodeoxyglucose imaging in differentiation of benign from malignant lung/mediastinal lesions, Int J Radiat Oncol Biol Phys. Chest, vol.74114, issue.77, pp.928-331105, 1998.

I. Haas, U. Hauser, and U. Ganzer, The dilemma of follow-up in head and neck cancer patients, European Archives of Oto-Rhino-Laryngology, vol.258, issue.4, pp.177-83, 2001.
DOI : 10.1007/s004050100333

W. Halfpenny, S. Hain, L. Biassoni, M. Maisey, J. Sherman et al., A possible prognostic factor in head and neck cancer Uses and limitations of FDG positron emission tomography in patients with head and neck cancer, Br J Cancer. Laryngoscope, vol.86109, pp.512-6880, 1999.

A. Handra-luca, J. Hernandez, G. Mountzios, E. Taranchon, J. Lacau-st-guily et al., Excision Repair Cross Complementation Group 1 Immunohistochemical Expression Predicts Objective Response and Cancer-Specific Survival in Patients Treated by Cisplatin-Based Induction Chemotherapy for Locally Advanced Head and Neck Squamous Cell Carcinoma, Clinical Cancer Research, vol.13, issue.13, pp.3855-3864, 2007.
DOI : 10.1158/1078-0432.CCR-07-0252

S. Byrd, D. Compton, and C. , Evaluation of 18 F-fluorodeoxyglucose positron emission tomography and computed tomography with histopathologic correlation in the initial staging of head and neck cancer Head and neck sites Head and neck tumours, AJCC Cancer Staging Manual UICC TNM Classification of Malignant Tumours, pp.208-1729, 2002.

M. Hentschel, S. Appold, A. Schreiber, N. Abolmaali, A. Abramyuk et al., Early FDG PET at 10 or 20 Gy under chemoradiotherapy is prognostic for locoregional control and overall survival in patients with head and neck cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.25, issue.7, pp.1203-1214, 2011.
DOI : 10.1007/s00259-011-1759-3

D. Heuveling, R. De-bree, and G. Van-dongen, The potential role of non-FDG-PET in the management of head and neck cancer, Oral Oncology, vol.47, issue.1, pp.2-7, 2011.
DOI : 10.1016/j.oraloncology.2010.10.008

K. Higgins, J. Hoang, M. Roach, J. Chino, D. Yoo et al., Analysis of Pretreatment FDG-PET SUV Parameters in Head-and-Neck Cancer: Tumor SUVmean Has Superior Prognostic Value, International Journal of Radiation Oncology*Biology*Physics, vol.82, issue.2, pp.548-53, 2012.
DOI : 10.1016/j.ijrobp.2010.11.050

H. Hoshikawa, Y. Nishiyama, T. Kishino, Y. Yamamoto, R. Haba et al., Comparison of FLT-PET and FDG-PET for Visualization of Head and Neck Squamous Cell Cancers, Molecular Imaging and Biology, vol.33, issue.1, pp.172-179, 2011.
DOI : 10.1007/s11307-010-0331-z

M. Houseni, W. Chamroonrat, J. Zhuang, R. Gopal, A. Alavi et al., Prognostic Implication of Dual-Phase PET in Adenocarcinoma of the Lung, Journal of Nuclear Medicine, vol.51, issue.4, pp.535-577, 2010.
DOI : 10.2967/jnumed.109.068643

S. Huang, J. Bock, and P. Harari, Epidermal growth factor receptor blockade with C225 modulates proliferation, apoptosis, and radiosensitivity in squamous-cell carcinomas of the head and neck, Cancer Res, vol.59, pp.1935-1975, 1999.

R. Hustinx, R. Smith, F. Benard, D. Rosenthal, M. Machtay et al., Dual time point fluorine-18 fluorodeoxyglucose positron emission tomography: a potential method to differentiate malignancy from inflammation and normal tissue in the head and neck, European Journal of Nuclear Medicine, vol.26, issue.10, pp.1345-1353, 1999.
DOI : 10.1007/s002590050593

M. Hutchings, A. Loft, M. Hansen, L. Pedersen, T. Buhl et al., FDG-PET after two cycles of chemotherapy predicts treatment failure and progression-free survival in Hodgkin lymphoma, Blood, vol.107, issue.1, pp.52-61, 2006.
DOI : 10.1182/blood-2005-06-2252

M. Hutchings, N. Mikhaeel, P. Fields, T. Nunan, and A. Timothy, Prognostic value of interim FDG-PET after two or three cycles of chemotherapy in Hodgkin lymphoma, Annals of Oncology, vol.16, issue.7, pp.1160-1168, 2005.
DOI : 10.1093/annonc/mdi200

S. Hyun, J. Choi, Y. Shim, K. Kim, S. Lee et al., Prognostic value of metabolic tumor volume measured by 18F-fluorodeoxyglucose positron emission tomography in patients with oesophageal carcinoma A systematic review and meta-analysis of the role of positron emission tomography in the follow up of head and neck squamous cell carcinoma following radiotherapy or chemoradiotherapy, Ann Surg Oncol Clin Otolaryngol, vol.1733, pp.115-22210, 2008.

C. Kao, S. Changlai, P. Chieng, R. Yen, and T. Yen, Detection of recurrent or persistent nasopharyngeal carcinomas after radiotherapy with 18-fluoro-2-deoxyglucose positron emission tomography and comparison with computed tomography., Journal of Clinical Oncology, vol.16, issue.11, pp.3550-3555, 1998.
DOI : 10.1200/JCO.1998.16.11.3550

C. Kao, S. Lin, T. Hsieh, K. Yen, S. Yang et al., Use of pretreatment metabolic tumour volumes to predict the outcome of pharyngeal cancer treated by definitive radiotherapy, European Journal of Nuclear Medicine and Molecular Imaging, vol.39, issue.8, pp.1297-305, 2012.
DOI : 10.1007/s00259-012-2127-7

V. Kapoor, M. Fukui, and B. Mccook, FDG PET/CT in the Treatment of Head and Neck Cancers: Posttherapy Evaluation and Pitfalls, American Journal of Roentgenology, vol.184, issue.2, pp.589-97, 2005.
DOI : 10.2214/ajr.184.2.01840589

D. Kim, S. Jung, C. Kim, and S. Park, The Efficacy of Dual Time Point F-18 FDG PET Imaging for Grading of Brain Tumors, Clinical Nuclear Medicine, vol.35, issue.6, pp.400-403, 2010.
DOI : 10.1097/RLU.0b013e3181db4cfb

K. Kim, S. Kim, I. Kim, Y. Kim, K. Pak et al., Prognostic value of volumetric parameters measured by F-18 FDG PET/CT in surgically resected non-small-cell lung cancer, Nuclear Medicine Communications, vol.33, issue.6
DOI : 10.1097/MNM.0b013e328351d4f5

S. Kim, Y. Kim, I. Kim, Y. Kim, and M. Lee, Limited prognostic value of dual time point F-18 FDG PET/CT in patients with early stage (stage I & II) non-small cell lung cancer (NSCLC), Radiotherapy and Oncology, vol.98, issue.1, pp.105-113, 2011.
DOI : 10.1016/j.radonc.2010.11.007

E. Ko, E. Genden, K. Misiukiewicz, P. Som, L. Kostakoglu et al., Toxicity profile and clinical outcomes in locally advanced head and neck cancer patients treated with induction chemotherapy prior to concurrent chemoradiation, Oncology Reports, vol.27, pp.467-74, 2012.
DOI : 10.3892/or.2011.1512

M. Koshy, A. Paulino, R. Howell, D. Schuster, R. Halkar et al., F-18 FDG PET-CT fusion in radiotherapy treatment planning for head and neck cancer, Head & Neck, vol.51, issue.6, pp.494-502, 2005.
DOI : 10.1002/hed.20179

K. Kubota, J. Yokoyama, K. Yamaguchi, S. Ono, A. Qureshy et al., FDG-PET delayed imaging for the detection of head and neck cancer recurrence after radio-chemotherapy: comparison with MRI/CT, European Journal of Nuclear Medicine and Molecular Imaging, vol.31, issue.4, pp.590-595, 2004.
DOI : 10.1007/s00259-003-1408-6

M. Kunkel, G. Förster, T. Reichert, J. Jeong, P. Benz et al., F]-2-fluorodeoxyglucose-positron emission tomography, Cancer, vol.86, issue.10, pp.2257-65, 2003.
DOI : 10.1002/cncr.11763

P. Kyzas, E. Evangelou, D. Denaxa-kyza, and J. Ioannidis, 18F-Fluorodeoxyglucose Positron Emission Tomography to Evaluate Cervical Node Metastases in Patients With Head and Neck Squamous Cell Carcinoma: A Meta-analysis, JNCI Journal of the National Cancer Institute, vol.100, issue.10, pp.712-732, 2008.
DOI : 10.1093/jnci/djn125

T. La, E. Fillion, B. Turnbull, J. Chu, P. Lee et al., Metabolic Tumor Volume Predicts for Recurrence and Death in Head-and-Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.74, issue.5, pp.1335-1376, 2009.
DOI : 10.1016/j.ijrobp.2008.10.060

K. Laimer, G. Spizzo, P. Obrist, G. Gastl, T. Brunhuber et al., STAT1 activation in squamous cell cancer of the oral cavity, Cancer, vol.95, issue.2, pp.326-359, 2007.
DOI : 10.1002/cncr.22813

J. Langendijk, B. Slotman, I. Van-der-waal, P. Doornaert, J. Berkof et al., Risk-group definition by recursive partitioning analysis of patients with squamous cell head and neck carcinoma treated with surgery and postoperative radiotherapy, Cancer, vol.86, issue.7, pp.1408-1425, 2005.
DOI : 10.1002/cncr.21340

M. Lapela, A. Eigtved, S. Jyrkkiö, R. Grénman, T. Kurki et al., Experience in qualitative and quantitative FDG PET in follow-up of patients with suspected recurrence from head and neck cancer, European Journal of Cancer, vol.36, issue.7, pp.858-67, 2000.
DOI : 10.1016/S0959-8049(00)00037-X

M. Lapela, R. Grénman, T. Kurki, H. Joensuu, S. Leskinen et al., Head and neck cancer: detection of recurrence with PET and 2-[F-18]fluoro-2-deoxy-D-glucose., Radiology, vol.197, issue.1
DOI : 10.1148/radiology.197.1.7568825

D. Lee, S. Kim, H. Lee, S. Lee, S. Park et al., Early Prediction of Response to First-Line Therapy Using Integrated 18F-FDG PET/CT for Patients with Advanced/Metastatic Non-small Cell Lung Cancer, Journal of Thoracic Oncology, vol.4, issue.7, pp.816-837, 2009.
DOI : 10.1097/JTO.0b013e3181a99fde

J. Lee, Segmentation of positron emission tomography images: Some recommendations for target delineation in radiation oncology, Radiotherapy and Oncology, vol.96, issue.3, pp.302-309, 2010.
DOI : 10.1016/j.radonc.2010.07.003

N. Lee, J. Mechalakos, S. Nehmeh, Z. Lin, O. Squire et al., Fluorine-18-Labeled Fluoromisonidazole Positron Emission and Computed Tomography-Guided Intensity-Modulated Radiotherapy for Head and Neck Cancer: A Feasibility Study, International Journal of Radiation Oncology*Biology*Physics, vol.70, issue.1, pp.2-13, 2008.
DOI : 10.1016/j.ijrobp.2007.06.039

M. Leel, U. Baum, H. Greess, A. Nömayr, E. Nkenke et al., Head and neck tumors: imaging recurrent tumor and post-therapeutic changes with CT and MRI, European Journal of Radiology, vol.33, issue.3, pp.239-286, 2000.
DOI : 10.1016/S0720-048X(99)00120-5

C. Leemans, R. Tiwari, J. Nauta, I. Van-der-waal, and G. Snow, Recurrence at the primary site in head and neck cancer and the significance of neck lymph node metastases as a prognostic factor, Cancer, vol.13, issue.1, pp.187-90, 1994.
DOI : 10.1002/1097-0142(19940101)73:1<187::AID-CNCR2820730132>3.0.CO;2-J

N. Liberato, C. Rognoni, S. Rubrichi, S. Quaglini, M. Marchetti et al., Adding docetaxel to cisplatin and fluorouracil in patients with unresectable head and neck cancer: a cost-utility analysis, Annals of Oncology, vol.23, issue.7, pp.1825-1857, 2012.
DOI : 10.1093/annonc/mdr545

R. Lim, A. Eaton, N. Lee, J. Setton, N. Ohri et al., 18F-FDG PET/CT Metabolic Tumor Volume and Total Lesion Glycolysis Predict Outcome in Oropharyngeal Squamous Cell Carcinoma, Journal of Nuclear Medicine, vol.53, issue.10, pp.1506-1519, 2012.
DOI : 10.2967/jnumed.111.101402

T. Liu, W. Xu, W. Yan, M. Ye, Y. Bai et al., FDG-PET, CT, MRI for diagnosis of local residual or recurrent nasopharyngeal carcinoma, which one is the best? A systematic review, Radiotherapy and Oncology, vol.85, issue.3, pp.327-362, 2007.
DOI : 10.1016/j.radonc.2007.11.002

F. Lordick, K. Ott, B. Krause, W. Weber, K. Becker et al., PET to assess early metabolic response and to guide treatment of adenocarcinoma of the oesophagogastric junction: the MUNICON phase II trial, The Lancet Oncology, vol.8, issue.9, pp.797-805, 2007.
DOI : 10.1016/S1470-2045(07)70244-9

V. Lowe, J. Boyd, F. Dunphy, H. Kim, T. Dunleavy et al., Surveillance for Recurrent Head and Neck Cancer Using Positron Emission Tomography, Journal of Clinical Oncology, vol.18, issue.3, pp.651-659, 2000.
DOI : 10.1200/JCO.2000.18.3.651

A. Lyshchik, T. Higashi, Y. Nakamoto, K. Fujimoto, R. Doi et al., Dual-phase 18F-fluoro-2-deoxy-d-glucose positron emission tomography as a prognostic parameter in patients with pancreatic cancer, European Journal of Nuclear Medicine and Molecular Imaging, vol.27, issue.4, pp.389-97, 2005.
DOI : 10.1007/s00259-004-1656-0

J. Malone, M. Gerberi, S. Vasireddy, L. Hughes, K. Rao et al., Early Prediction of Response to Chemoradiotherapy for Head and Neck Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.135, issue.11, pp.1119-1144, 2009.
DOI : 10.1001/archoto.2009.152

A. Mavi, S. Basu, T. Cermik, M. Urhan, M. Bathaii et al., Potential of Dual Time Point FDG-PET Imaging in Differentiating Malignant from Benign Pleural Disease, Molecular Imaging and Biology, vol.89, issue.4
DOI : 10.1007/s11307-009-0212-5

M. Meignan, A. Gallamini, C. Haioun, and A. Polliack, Report on the Second international Workshop on interim positron emission tomography in lymphoma, pp.8-9

M. Meignan, A. Gallamini, and C. Haioun, Report on the First International Workshop on interim-PET scan in lymphoma, Leukemia & Lymphoma, vol.50, issue.8, pp.1257-60, 2009.
DOI : 10.1007/s00259-008-0787-0

M. Meignan, A. Gallamini, E. Itti, S. Barrington, C. Haioun et al., Report on the Third international Workshop on Interim Positron Emission Tomography in Lymphoma Consensus, Leuk Lymphoma, vol.53, pp.26-271876, 2011.

C. Messa, Y. Choi, C. Hoh, E. Jacobs, J. Glaspy et al., Quantification of Glucose Utilization in Liver Metastases, Journal of Computer Assisted Tomography, vol.16, issue.5, pp.684-693, 1992.
DOI : 10.1097/00004728-199209000-00003

N. Mikhaeel, M. Hutchings, P. Fields, O. Doherty, M. Timothy et al., FDG-PET after two to three cycles of chemotherapy predicts progression-free and overall survival in high-grade non-Hodgkin lymphoma, Annals of Oncology, vol.16, issue.9, pp.1514-1537, 2005.
DOI : 10.1093/annonc/mdi272

T. Miller and P. Grigsby, Measurement of tumor volume by PET to evaluate prognosis in patients with advanced cervical cancer treated by radiation therapy, International Journal of Radiation Oncology*Biology*Physics, vol.53, issue.2, pp.353-362, 2002.
DOI : 10.1016/S0360-3016(02)02705-0

M. Miyakubo, N. Oriuchi, Y. Tsushima, T. Higuchi, K. Koyama et al., Diagnosis of maxillofacial tumor withl-3-[18F]-fluoro-??-methyltyrosine (FMT) PET: a comparative study with FDG-PET, Annals of Nuclear Medicine, vol.19, issue.2, pp.129-164, 2007.
DOI : 10.1007/BF03033991

F. Montravers, D. Grahek, K. Kerrou, N. Younsi, D. Beco et al., La tomographie par émission de positopns au [18F]-Fluoro-2-desoxyglucose : revue de la littérature et de nos résultats dans les cancers extrapulmonaires, Med Nucl, vol.23, pp.151-160, 1999.

F. /. Pet, CT in patients with squamous cell carcinoma of the tonsil: comparison of volumebased metabolic parameters, Head Neck, vol.35, pp.15-22, 2013.

S. Moon, S. Hyun, and J. Choi, Prognostic Significance of Volume-Based PET Parameters in Cancer Patients, Korean Journal of Radiology, vol.14, issue.1, pp.1-12, 2013.
DOI : 10.3348/kjr.2013.14.1.1

S. Ng, T. Yen, J. Chang, S. Chan, S. Ko et al., F]Fluorodeoxyglucose Positron Emission Tomography and Computed Tomography and Magnetic Resonance Imaging in Oral Cavity Squamous Cell Carcinoma With Palpably Negative Neck, Journal of Clinical Oncology, vol.24, issue.27, pp.4367-4375, 2006.
DOI : 10.1200/JCO.2006.05.7349

E. Nitzsche, S. Hoegerle, M. Mix, I. Brink, A. Otte et al., Non-invasive differentiation of pancreatic lesions: is analysis of FDG kinetics superior to semiquantitative uptake value analysis?, European Journal of Nuclear Medicine and Molecular Imaging, vol.29, issue.2, pp.237-279, 2002.
DOI : 10.1007/s00259-001-0697-x

B. Nowak, D. Martino, E. Jänicke, S. Cremerius, U. Adam et al., Diagnostic evaluation of malignant head and neck cancer by F-18-FDG PET compared to CT

J. Nuutinen, S. Jyrkkio, P. Lehikoinen, P. Lindholm, and H. Minn, Evaluation of early response to radiotherapy in head and neck cancer measured with [11C]methionine-positron emission tomography, Radiotherapy and Oncology, vol.52, issue.3, pp.225-257, 1999.
DOI : 10.1016/S0167-8140(99)00091-2

K. Ott, U. Fink, K. Becker, A. Stahl, H. Dittler et al., Prediction of Response to Preoperative Chemotherapy in Gastric Carcinoma by Metabolic Imaging: Results of a Prospective Trial, Journal of Clinical Oncology, vol.21, issue.24, pp.4604-4614, 2003.
DOI : 10.1200/JCO.2003.06.574

D. Parkin, F. Bray, J. Ferlay, and P. Pisani, Global Cancer Statistics, 2002, CA: A Cancer Journal for Clinicians, vol.55, issue.2, pp.74-108, 2002.
DOI : 10.3322/canjclin.55.2.74

A. Parthan, M. Posner, C. Brammer, P. Beltran, and J. Jansen, Cost utility of docetaxel as induction chemotherapy followed by chemoradiation in locally advanced squamous cell carcinoma of the head and neck, Head & Neck, vol.13, issue.10, pp.1255-62, 2009.
DOI : 10.1002/hed.21096

C. Patlak and R. Blasberg, Graphical Evaluation of Blood-to-Brain Transfer Constants from Multiple-Time Uptake Data. Generalizations, Journal of Cerebral Blood Flow & Metabolism, vol.226, issue.4, pp.584-90, 1985.
DOI : 10.1038/jcbfm.1985.87

R. Paul, D. Roeda, R. Johansson, A. Ahonen, M. Haaparanta et al., Scintigraphy with [18F]2-fluoro-2-deoxy-d-glucose of cancer patients, International Journal of Radiation Applications and Instrumentation. Part B. Nuclear Medicine and Biology, vol.13, issue.1, pp.7-12, 1986.
DOI : 10.1016/0883-2897(86)90245-X

D. Pauleit, A. Zimmermann, G. Stoffels, D. Bauer, J. Risse et al., 18F-FET PET compared with 18F-FDG PET and CT in patients with head and neck cancer, J Nucl Med, vol.47, pp.256-61, 2006.

L. Perk, G. Visser, M. Vosjan, M. Stigter-van-walsum, B. Tijink et al., 89Zr as a PET surrogate radioisotope for scouting biodistribution of the therapeutic radiometals 90Y and 177Lu in tumor-bearing nude mice after coupling to the internalizing antibody cetuximab, J Nucl Med, vol.46, pp.1898-906, 2005.

M. Phelps, S. Huang, E. Hoffman, L. Sokoloff, and D. Kuhl, Tomographic measurement of local cerebral glucose metabolic rate in humans with (F-18)2-fluoro-2-deoxy-D-glucose: Validation of method, Annals of Neurology, vol.220, issue.5, pp.371-88, 1979.
DOI : 10.1002/ana.410060502

M. Phillips, W. Smith, U. Parvathaneni, and G. Laramore, Role of Positron Emission Tomography in the Treatment of Occult Disease in Head-and-Neck Cancer: A Modeling Approach, International Journal of Radiation Oncology*Biology*Physics, vol.79, issue.4
DOI : 10.1016/j.ijrobp.2009.12.037

L. Pignataro, G. Pruneri, N. Carboni, P. Capaccio, B. Cesana et al., Clinical relevance of cyclin D1 protein overexpression in laryngeal squamous cell carcinoma., Journal of Clinical Oncology, vol.16, issue.9, pp.3069-77, 1998.
DOI : 10.1200/JCO.1998.16.9.3069

M. Posner, D. Hershock, C. Blajman, E. Mickiewicz, E. Winquist et al., Cisplatin and Fluorouracil Alone or with Docetaxel in Head and Neck Cancer, New England Journal of Medicine, vol.357, issue.17, pp.1705-1720, 2007.
DOI : 10.1056/NEJMoa070956

J. Prior, M. Montemurro, M. Orcurto, O. Michielin, F. Luthi et al., F-Fluorodeoxyglucose Positron Emission Tomography in Patients With Gastrointestinal Stromal Tumor, Journal of Clinical Oncology, vol.27, issue.3, pp.439-484, 2009.
DOI : 10.1200/JCO.2008.17.2742

S. Querellou, R. Abgral, P. Le-roux, E. Nowak, G. Valette et al., Prognostic value of fluorine-18 fluorodeoxyglucose positron-emission tomography imaging in patients with head and neck squamous cell carcinoma, Head & Neck, vol.38, issue.4, pp.462-470, 2012.
DOI : 10.1002/hed.21765

URL : https://hal.archives-ouvertes.fr/hal-00759315

A. Riegel, A. Berson, and S. Destian, Variability of gross tumor volume delineation in head-and-neck cancer using CT and PET/CT fusion, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.3, pp.726-758, 2006.
DOI : 10.1016/j.ijrobp.2006.01.014

D. Rischin, R. Hicks, R. Fischer, D. Binns, C. J. Porceddu et al., F]-Misonidazole Positron Emission Tomography???Detected Tumor Hypoxia in Patients With Advanced Head and Neck Cancer Randomly Assigned to Chemoradiation With or Without Tirapazamine: A Substudy of Trans-Tasman Radiation Oncology Group Study 98.02, Journal of Clinical Oncology, vol.24, issue.13
DOI : 10.1200/JCO.2005.05.2878

J. Roh, J. Kim, J. Lee, K. Cho, S. Choi et al., Utility of combined 18F-fluorodeoxyglucose-positron emission tomography and computed tomography in patients with cervical metastases from unknown primary tumors, Oral Oncology, vol.45, issue.3, pp.218-242, 2009.
DOI : 10.1016/j.oraloncology.2008.05.010

S. Rothschild, G. Studer, and B. Seifert, CT staging followed by intensitymodulated radiotherapy (IMRT) improves treatment outcome of locally advanced pharyngeal carcinoma: a matched-pair comparison, Radiat Oncol, vol.9, pp.22-32, 2007.

K. Rusthoven, M. Koshy, and A. Paulino, The role of fluorodeoxyglucose positron emission tomography in cervical lymph node metastases from an unknown primary tumor, Cancer, vol.290, issue.11
DOI : 10.1002/cncr.20687

W. Ryan, E. Willard, L. Quynh-thu, and A. Harlan, Positron-Emission Tomography for Surveillance of Head and Neck Cancer, The Laryngoscope, vol.69, issue.4, pp.645-50, 2005.
DOI : 10.1097/01.mlg.0000161345.23128.d4

P. Salaün, R. Abgral, S. Querellou, O. Couturier, G. Valette et al., Does 18fluoro-fluorodeoxyglucose positron emission tomography improve recurrence detection in patients cured of head and neck squamous cell carcinoma with negative clinical follow up? Head Neck, pp.1115-1135, 2007.

B. Sanghera, W. Wong, M. Lodge, C. Hain, D. Stott et al., Potential novel application of dual time point SUV measurements as a predictor of survival in head and neck cancer, Nuclear Medicine Communications, vol.26, issue.10, pp.861-868, 2005.
DOI : 10.1097/00006231-200510000-00003

Y. Satoh, A. Nambu, H. Onishi, E. Sawada, L. Tominaga et al., Value of dual time point F-18 FDG-PET/CT imaging for the evaluation of prognosis and risk factors for recurrence in patients with stage I non-small cell lung cancer treated with stereotactic body radiation therapy, European Journal of Radiology, vol.81, issue.11, pp.3530-3534, 2012.
DOI : 10.1016/j.ejrad.2011.11.047

M. Schelling, N. Avril, J. Nährig, W. Kuhn, W. Römer et al., F]Fluorodeoxyglucose for Monitoring Primary Chemotherapy in Breast Cancer, Journal of Clinical Oncology, vol.18, issue.8, pp.1689-95, 2000.
DOI : 10.1200/JCO.2000.18.8.1689

D. Schinagl, J. Kaanders, and W. Oyen, From anatomical to biological target volumes: the role of PET in radiation treatment planning, Cancer Imaging, vol.6, issue.Special Issue A, pp.107-123, 2006.
DOI : 10.1102/1470-7330.2006.9017

D. Schwartz, E. Ford, J. Rajendran, B. Yueh, M. Coltrera et al., FDG-PET/CT imaging for preradiotherapy staging of head-and-neck squamous cell carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.61, issue.1, pp.129-165, 2005.
DOI : 10.1016/j.ijrobp.2004.03.040

L. Schwartz, M. Ozsahin, G. Zhang, E. Touboul, D. Vataire et al., Synchronous and metachronous head and neck carcinomas, Cancer, vol.9, issue.7, pp.1933-1941, 1994.
DOI : 10.1002/1097-0142(19941001)74:7<1933::AID-CNCR2820740718>3.0.CO;2-X

J. Schwarz, M. Bader, L. Jenicke, G. Hemminger, F. Jänicke et al., Early prediction of response to chemotherapy in metastatic breast cancer using sequential 18F-FDG PET, J Nucl Med, vol.46, pp.1144-50, 2005.

Y. Seol, Y. Kwon, B. Kwon, Y. Choi, H. Shin et al., Measurement of tumor volume by PET to evaluate prognosis in patients with head and neck cancer treated by chemo-radiation therapy, Acta Oncologica, vol.53, issue.2, pp.201-209, 2010.
DOI : 10.2967/jnumed.107.039610

K. Shima, I. Kobayashi, I. Saito, T. Kiyoshima, K. Matsuo et al., Incidence of human papillomavirus 16 and 18 infection and p53 mutation in patients with oral squamous cell carcinoma in Japan, British Journal of Oral and Maxillofacial Surgery, vol.38, issue.5, pp.445-50, 2000.
DOI : 10.1054/bjom.2000.0162

C. Sittel, H. Eckel, M. Damm, E. Von-pritzbuer, and H. Kvasnicka, Ki-67 (MIB1), p53, and Lewis-X (LeuM1) as Prognostic Factors of Recurrence in T1 and T2 Laryngeal Carcinoma, The Laryngoscope, vol.15, issue.6
DOI : 10.1097/00005537-200006000-00024

C. Sittel, S. Ruiz, P. Volling, H. Kvasnicka, M. Jungehulsing et al., Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity, Oral Oncology, vol.35, issue.6, pp.583-592, 1999.
DOI : 10.1016/S1368-8375(99)00041-X

I. Smith, A. Welch, A. Hutcheon, I. Miller, S. Payne et al., -Glucose to Predict the Pathologic Response of Breast Cancer to Primary Chemotherapy, Journal of Clinical Oncology, vol.18, issue.8, pp.1676-88, 2000.
DOI : 10.1200/JCO.2000.18.8.1676

URL : https://hal.archives-ouvertes.fr/hal-00309731

D. Soto, M. Kessler, M. Piert, and A. Eisbruch, Correlation between pretreatment FDG-PET biological target volume and anatomical location of failure after radiation therapy for head and neck cancers, Radiotherapy and Oncology, vol.89, issue.1, pp.13-18, 2009.
DOI : 10.1016/j.radonc.2008.05.021

M. Souvatzoglu, A. Grosu, B. Roper, B. Krause, R. Beck et al., Tumour hypoxia imaging with [18F]FAZA PET in head and neck cancer patients: a pilot study, European Journal of Nuclear Medicine and Molecular Imaging, vol.45, issue.10, pp.1566-75, 2007.
DOI : 10.1007/s00259-007-0424-3

M. Stokkel, K. Moons, T. Broek, F. Van-rijk, P. Hordijk et al., 18F-fluorodeoxyglucose dual-head positron emission tomography as a procedure for detecting simultaneous primary tumors in cases of head and neck cancer, Cancer, vol.39, issue.11, pp.2370-2377, 1999.
DOI : 10.1002/(SICI)1097-0142(19991201)86:11<2370::AID-CNCR27>3.0.CO;2-B

M. Stokkel, T. Broek, F. Van-rijk, and P. , Preoperative assessment of cervical lymph nodes in head and neck cancer with fluorine-18 fluorodeoxyglucose using a dual-head coincidence camera: a pilot study, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.5, pp.499-503, 1999.
DOI : 10.1007/s002590050417

M. Stokkel, C. Terhaard, G. Hordijk, and P. Van-rijk, The detection of local recurrent head and neck cancer with fluroine-18 fluorodeoxyglucose dual-head positron emission tomography, European Journal of Nuclear Medicine and Molecular Imaging, vol.26, issue.7, pp.767-73, 1999.
DOI : 10.1007/s002590050448

N. Sunaga, N. Oriuchi, K. Kaira, N. Yanagitani, Y. Tomizawa et al., Usefulness of FDG-PET for early prediction of the response to gefitinib in non-small cell lung cancer, Lung Cancer, vol.59, issue.2, pp.203-213, 2008.
DOI : 10.1016/j.lungcan.2007.08.012

S. Tandon, C. Tudur-smith, R. Riley, M. Boyd, and T. Jones, A Systematic Review of p53 as a Prognostic Factor of Survival in Squamous Cell Carcinoma of the Four Main Anatomical Subsites of the Head and Neck, Cancer Epidemiology Biomarkers & Prevention, vol.19, issue.2, pp.574-87, 2010.
DOI : 10.1158/1055-9965.EPI-09-0981

C. Tang, J. Murphy, B. Khong, T. La, C. Kong et al., Validation that Metabolic Tumor Volume Predicts Outcome in Head-and-Neck Cancer, International Journal of Radiation Oncology*Biology*Physics, vol.83, issue.5, pp.1514-1534, 2012.
DOI : 10.1016/j.ijrobp.2011.10.023

S. Temam, H. Kawaguchi, A. El-naggar, J. Jelinek, H. Tang et al., Epidermal Growth Factor Receptor Copy Number Alterations Correlate With Poor Clinical Outcome in Patients With Head and Neck Squamous Cancer, Journal of Clinical Oncology, vol.25, issue.16, pp.2164-70, 2007.
DOI : 10.1200/JCO.2006.06.6605

C. Terhaard, V. Bongers, P. Van-rijk, and G. Hordijk, F-18-fluoro-deoxy-glucose positron-emission tomography scanning in detection of local recurrence after radiotherapy for laryngeal/ pharyngeal cancer, Head & Neck, vol.39, issue.11, pp.933-974, 2001.
DOI : 10.1002/hed.1135

R. Tian, M. Su, Y. Tian, F. Li, L. Li et al., Dual-time point PET/CT with F-18 FDG for the differentiation of malignant and benign bone lesions, Skeletal Radiology, vol.35, issue.11, pp.451-459, 2009.
DOI : 10.1007/s00256-008-0643-0

C. Van-de-wiele, V. Kruse, P. Smeets, M. Sathekge, and A. Maes, Predictive and prognostic value of metabolic tumour volume and total lesion glycolysis in solid tumours, European Journal of Nuclear Medicine and Molecular Imaging, vol.23, issue.5 Suppl, pp.290-301, 2013.
DOI : 10.1007/s00259-012-2280-z

M. Vanderhoek, S. Perlman, and R. Jeraj, Impact of the Definition of Peak Standardized Uptake Value on Quantification of Treatment Response, Journal of Nuclear Medicine, vol.53, issue.1, pp.4-11, 2012.
DOI : 10.2967/jnumed.111.093443

P. Vera, S. Thureau, and P. Bohn, Positrons emission tomography tracers for hypoxia imaging, Med Nucl, vol.35, pp.433-477, 2011.

J. Vicente, A. Herrero-zapatero, M. Fresno, and J. Lopez-arranz, Expression of cyclin D1 and Ki-67 in squamous cell carcinoma of the oral cavity: clinicopathological and prognostic significance, Oral Oncology, vol.38, issue.3, pp.301-309, 2002.
DOI : 10.1016/S1368-8375(01)00060-4

I. Alonso, A. Baroja, and C. De-la-hoz, p53 and cyclin D1 as prognostic factors in squamous cell carcinoma of the larynx, Larynoscope, vol.113, pp.167-72, 2003.

R. Wahl, H. Jacene, Y. Kasamon, and M. Lodge, From RECIST to PERCIST: Evolving Considerations for PET Response Criteria in Solid Tumors, Journal of Nuclear Medicine, vol.50, issue.Suppl_1, pp.122-50, 2009.
DOI : 10.2967/jnumed.108.057307

R. Wahl, Targeting glucose transporters for tumor imaging: " sweet " idea, " sour " result

M. Wanet, J. Lee, B. Weynand, M. De-bast, A. Poncelet et al., Gradient-based delineation of the primary GTV on FDG-PET in non-small cell lung cancer: A comparison with threshold-based approaches, CT and surgical specimens, Radiotherapy and Oncology, vol.98, issue.1, pp.117-142, 2011.
DOI : 10.1016/j.radonc.2010.10.006

D. Wang, C. Schultz, and P. Jursinic, Initial experience of FDG-PET/CT guided IMRT of head-and-neck carcinoma, International Journal of Radiation Oncology*Biology*Physics, vol.65, issue.1, pp.143-51, 2006.
DOI : 10.1016/j.ijrobp.2005.11.048

M. Wax, L. Myers, E. Gabalski, S. Husain, J. Gona et al., Positron Emission Tomography in the Evaluation of Synchronous Lung Lesions in Patients With Untreated Head and Neck Cancer, Archives of Otolaryngology???Head & Neck Surgery, vol.128, issue.6, pp.703-710, 2002.
DOI : 10.1001/archotol.128.6.703

W. Weber, V. Petersen, B. Schmidt, L. Tyndale-hines, T. Link et al., Positron Emission Tomography in Non???Small-Cell Lung Cancer: Prediction of Response to Chemotherapy by Quantitative Assessment of Glucose Use, Journal of Clinical Oncology, vol.21, issue.14, pp.2651-57, 2003.
DOI : 10.1200/JCO.2003.12.004

H. Wieder, B. Brücher, F. Zimmermann, K. Becker, F. Lordick et al., Time Course of Tumor Metabolic Activity During Chemoradiotherapy of Esophageal Squamous Cell Carcinoma and Response to Treatment, Journal of Clinical Oncology, vol.22, issue.5, pp.900-908, 2004.
DOI : 10.1200/JCO.2004.07.122

R. Wong, D. Lin, H. Schöder, S. Patel, M. Gonen et al., F]Fluorodeoxyglucose Positron Emission Tomography for Recurrent Head and Neck Squamous Cell Carcinoma, Journal of Clinical Oncology, vol.20, issue.20, pp.4199-208, 2002.
DOI : 10.1200/JCO.2002.02.590

R. Wong, Current status of FDG-PET for head and neck cancer, Journal of Surgical Oncology, vol.46, issue.8, pp.649-52, 2008.
DOI : 10.1002/jso.21018

H. Wu, Q. Wang, M. Wang, X. Zhen, W. Zhou et al., Preliminary Study of 11C-Choline PET/CT for T Staging of Locally Advanced Nasopharyngeal Carcinoma: Comparison with 18F-FDG PET/CT, Journal of Nuclear Medicine, vol.52, issue.3, pp.341-387, 2011.
DOI : 10.2967/jnumed.110.081190

D. Zhu, T. Ma, Z. Niu, J. Zheng, A. Han et al., Prognostic significance of metabolic parameters measured by 18F-fluorodeoxyglucose positron emission tomography/computed tomography in patients with small cell lung cancer, Lung Cancer, vol.73, issue.3, pp.332-339, 2001.
DOI : 10.1016/j.lungcan.2011.01.007